Zeng S - Search Results

1

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.

Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A. Gheibi P, et al. Among authors: zeng s. Sci Rep. 2017 Sep 25;7(1):12277. doi: 10.1038/s41598-017-12543-9. Sci Rep. 2017. PMID: 28947782 Free PMC article.

2

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.

Zeng SX, Zhu Y, Ma AH, Yu W, Zhang H, Lin TY, Shi W, Tepper CG, Henderson PT, Airhart S, Guo JM, Xu CL, deVere White RW, Pan CX. Zeng SX, et al. Clin Cancer Res. 2017 Nov 1;23(21):6580-6591. doi: 10.1158/1078-0432.CCR-17-0033. Epub 2017 Aug 14. Clin Cancer Res. 2017. PMID: 28808038 Free PMC article.

3

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.

Zeng S, Yu X, Ma C, Song R, Zhang Z, Zi X, Chen X, Wang Y, Yu Y, Zhao J, Wei R, Sun Y, Xu C. Zeng S, et al. Sci Rep. 2017 Jun 9;7(1):3151. doi: 10.1038/s41598-017-02990-9. Sci Rep. 2017. PMID: 28600503 Free PMC article.

4

Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.

Liu A, Zhang Z, Xu W, Qin S, Hua M, Zeng S, Xu C. Liu A, et al. Among authors: zeng s. Mol Med Rep. 2018 Dec;18(6):5437-5444. doi: 10.3892/mmr.2018.9597. Epub 2018 Oct 25. Mol Med Rep. 2018. PMID: 30365104 Free PMC article.

5

Tumor‑infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.

Xue Y, Tong L, LiuAnwei Liu F, Liu A, Zeng S, Xiong Q, Yang Z, He X, Sun Y, Xu C. Xue Y, et al. Among authors: zeng s. Oncol Rep. 2019 Aug;42(2):581-594. doi: 10.3892/or.2019.7196. Epub 2019 Jun 12. Oncol Rep. 2019. PMID: 31233191 Free PMC article.

6

Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer.

Wang KJ, Wang C, Dai LH, Yang J, Huang H, Ma XJ, Zhou Z, Yang ZY, Xu WD, Hua MM, Lu X, Zeng SX, Wang HQ, Zhang ZS, Cheng YQ, Liu D, Tian QQ, Sun YH, Xu CL. Wang KJ, et al. Clin Cancer Res. 2019 Feb 1;25(3):1070-1086. doi: 10.1158/1078-0432.CCR-18-0586. Epub 2018 Nov 5. Clin Cancer Res. 2019. PMID: 30397177

7

Identifying the grade of bladder cancer cells using microfluidic chips based on impedance.

Fan W, Xiong Q, Ge Y, Liu T, Zeng S, Zhao J. Fan W, et al. Among authors: zeng s. Analyst. 2022 Apr 11;147(8):1722-1729. doi: 10.1039/d2an00026a. Analyst. 2022. PMID: 35343521

8

Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.

Zhao J, Xu W, Zhang Z, Song R, Zeng S, Sun Y, Xu C. Zhao J, et al. Among authors: zeng s. Int Urol Nephrol. 2015 Jan;47(1):87-94. doi: 10.1007/s11255-014-0866-z. Epub 2014 Nov 11. Int Urol Nephrol. 2015. PMID: 25384433 Review.

9

Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response.

Xiong Q, Liu T, Ying Y, Yu X, Wang Z, Gao H, Lin T, Fan W, Zhang Z, Wei Q, Ge Y, Zeng S, Xu C. Xiong Q, et al. Among authors: zeng s. Bioeng Transl Med. 2023 Dec 4;9(2):e10624. doi: 10.1002/btm2.10624. eCollection 2024 Mar. Bioeng Transl Med. 2023. PMID: 38435820 Free PMC article.

10

Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer.

Xiong Q, Feng D, Wang Z, Ying Y, Xu C, Wei Q, Zeng S, Yang L. Xiong Q, et al. Among authors: zeng s. Front Immunol. 2022 Mar 22;13:836939. doi: 10.3389/fimmu.2022.836939. eCollection 2022. Front Immunol. 2022. PMID: 35392075 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,730 results

Search Page

Filters